Wednesday, June 27, 2012

Doing the same thing and expecting different results

FDA approves Arena obesity drug
U.S. health regulators on Wednesday approved Arena Pharmaceuticals Inc's pill to treat obesity, making it the first new weight-loss drug in 13 years as public health advocates push for new solutions to the nation's growing obesity epidemic.
From the insert:   Belviq is a serotonin 2C receptor agonist.

It's another antidepressant.